17-31227549-G-T
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PS1PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_001042492.3(NF1):c.2352G>T(p.Trp784Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W784R) has been classified as Pathogenic.
Frequency
Consequence
NM_001042492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.2352G>T | p.Trp784Cys | missense_variant | 20/58 | ENST00000358273.9 | NP_001035957.1 | |
NF1 | NM_000267.3 | c.2352G>T | p.Trp784Cys | missense_variant | 20/57 | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NF1 | ENST00000358273.9 | c.2352G>T | p.Trp784Cys | missense_variant | 20/58 | 1 | NM_001042492.3 | ENSP00000351015.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2020 | The p.W784C variant (also known as c.2352G>T), located in coding exon 20 of the NF1 gene, results from a G to T substitution at nucleotide position 2352. The tryptophan at codon 784 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration has been reported in an individual suspected of having neurofibromatosis type 1 (NF1) (Griffiths S et al. Fam Cancer, 2007;6:21-34). A different nucleotide change leading to the same amino acid substitution, c.2352G>C (p.W784C), has also been described in multiple patients with a clinical diagnosis of NF1 (Han SS et al. Hum Genet, 2001 Nov;109:487-97; Giugliano T et al. Genes (Basel), 2019 07;10:; Melloni G et al. Cancers (Basel), 2019 11;11:). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.